Acon Biotech (Hangzhou) Co., Ltd.
Acon Biotech (Hangzhou) Co., Ltd. appears in FDA public data with 1 recall, 0 510(k) clearances, 1 FDA inspection, and 0 compliance actions on record. Its most recent recall (Z-0945-2022, Class II) was initiated on January 9, 2022.
Summary
- Total Recalls
- 1
- 510(k) Clearances
- 0
- Inspections
- 1
- Compliance Actions
- 0
Recent Recalls
| Number | Class | Product | Date |
|---|---|---|---|
| Z-0945-2022 | Class II | Flowflex SARS-CoV-2 Antigen Rapid Test (Self-Testing), CE marked | January 9, 2022 |